Labots M - Search Results

1

Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types.

van der Wijngaart H, Hoes LR, van Berge Henegouwen JM, van der Velden DL, Zeverijn LJ, Roepman P, van Werkhoven E, de Leng WWJ, Jansen AML, Mehra N, Robbrecht DGJ, Labots M, de Groot DJA, Hoeben A, Hamberg P, Gelderblom H, Voest EE, Verheul HMW. van der Wijngaart H, et al. Among authors: labots m. Clin Cancer Res. 2021 Nov 15;27(22):6106-6114. doi: 10.1158/1078-0432.CCR-21-1104. Epub 2021 Sep 2. Clin Cancer Res. 2021. PMID: 34475104

2

Strategies for kinome profiling in cancer and potential clinical applications: chemical proteomics and array-based methods.

Piersma SR, Labots M, Verheul HM, Jiménez CR. Piersma SR, et al. Among authors: labots m. Anal Bioanal Chem. 2010 Aug;397(8):3163-71. doi: 10.1007/s00216-010-3784-7. Epub 2010 Jun 8. Anal Bioanal Chem. 2010. PMID: 20526883 Free article. Review.

3

Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance.

Gotink KJ, Broxterman HJ, Labots M, de Haas RR, Dekker H, Honeywell RJ, Rudek MA, Beerepoot LV, Musters RJ, Jansen G, Griffioen AW, Assaraf YG, Pili R, Peters GJ, Verheul HM. Gotink KJ, et al. Among authors: labots m. Clin Cancer Res. 2011 Dec 1;17(23):7337-46. doi: 10.1158/1078-0432.CCR-11-1667. Epub 2011 Oct 6. Clin Cancer Res. 2011. PMID: 21980135 Free PMC article.

4

High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.

Labots M, Buffart TE, Haan JC, van Grieken NC, Tijssen M, van de Velde CJ, Grabsch HI, Ylstra B, Carvalho B, Fijneman RJ, Verheul HM, Meijer GA. Labots M, et al. Cell Oncol (Dordr). 2014 Feb;37(1):41-52. doi: 10.1007/s13402-013-0162-4. Epub 2013 Dec 31. Cell Oncol (Dordr). 2014. PMID: 24379144

5

Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies.

Labots M, Schütte LM, van der Mijn JC, Pham TV, Jiménez CR, Verheul HM. Labots M, et al. Oncologist. 2014 Oct;19(10):1028-39. doi: 10.1634/theoncologist.2014-0101. Epub 2014 Sep 3. Oncologist. 2014. PMID: 25187478 Free PMC article. Review.

6

Therapeutic drug monitoring to individualize the dosing of pazopanib: a pharmacokinetic feasibility study.

de Wit D, van Erp NP, den Hartigh J, Wolterbeek R, den Hollander-van Deursen M, Labots M, Guchelaar HJ, Verheul HM, Gelderblom H. de Wit D, et al. Among authors: labots m. Ther Drug Monit. 2015 Jun;37(3):331-8. doi: 10.1097/FTD.0000000000000141. Ther Drug Monit. 2015. PMID: 25271729 Clinical Trial.

7

Genomic landscape of metastatic colorectal cancer.

Haan JC, Labots M, Rausch C, Koopman M, Tol J, Mekenkamp LJ, van de Wiel MA, Israeli D, van Essen HF, van Grieken NC, Voorham QJ, Bosch LJ, Qu X, Kabbarah O, Verheul HM, Nagtegaal ID, Punt CJ, Ylstra B, Meijer GA. Haan JC, et al. Among authors: labots m. Nat Commun. 2014 Nov 14;5:5457. doi: 10.1038/ncomms6457. Nat Commun. 2014. PMID: 25394515 Free PMC article. Clinical Trial.

8

Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines.

Piersma SR, Knol JC, de Reus I, Labots M, Sampadi BK, Pham TV, Ishihama Y, Verheul HM, Jimenez CR. Piersma SR, et al. Among authors: labots m. J Proteomics. 2015 Sep 8;127(Pt B):247-58. doi: 10.1016/j.jprot.2015.03.019. Epub 2015 Apr 1. J Proteomics. 2015. PMID: 25841592

9

Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics.

van der Mijn JC, Labots M, Piersma SR, Pham TV, Knol JC, Broxterman HJ, Verheul HM, Jiménez CR. van der Mijn JC, et al. Among authors: labots m. J Proteomics. 2015 Sep 8;127(Pt B):259-63. doi: 10.1016/j.jprot.2015.04.006. Epub 2015 Apr 16. J Proteomics. 2015. PMID: 25890253

10

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer.

Labots M, Gotink KJ, Dekker H, Azijli K, van der Mijn JC, Huijts CM, Piersma SR, Jiménez CR, Verheul HM. Labots M, et al. Exp Mol Med. 2016 Dec 16;48(12):e279. doi: 10.1038/emm.2016.114. Exp Mol Med. 2016. PMID: 27980342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page